ArticleInvestigational new drugs2025

A phase I study of liposomal Irinotecan (ONIVYDE®) in combination with TAS-102 (LONSURF®) in refractory solid tumors.

Nai-Jung Chiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.